Immunitybio, Inc.
$9.77
+0.22
(+2.25%)
US Company • (IBRX) • Biological Products, (No Diagnostic Substances)
ACCESSION NUMBER
0001189020-26-000003
FILING DATE
Feb 12, 2026
FORM TYPE
Form 4
REPORT DATE
Feb 10, 2026
AI Analysis Summary
Comments
▶
▶
Be the first to share your thoughts
Start a conversation about this filing. Your insights and analysis help the community better understand the document.
Sign Up to CommentJoin the conversation and share your analysis about this filing.
Create an Account to Comment